Short-term Pioglitazone treatment improves conduit artery endothelial function, increases adiponectin, and decreases CRP in type 2 diabetes.

Translated title of the contribution: Short-term Pioglitazone treatment improves conduit artery endothelial function, increases adiponectin, and decreases CRP in type 2 diabetes.

F. Martens, F.L.J. Visseren, E.J.P. de Koning, A.J. Rabelink

Research output: Contribution to journal › Article › Academic

Translated title of the contributionShort-term Pioglitazone treatment improves conduit artery endothelial function, increases adiponectin, and decreases CRP in type 2 diabetes.
Original languageUndefined/Unknown
Pages (from-to)773-778
Number of pages6
JournalJournal of Cardiovascular Pharmacology
Volume46
Publication statusPublished - 2005

Keywords

  • Econometric and Statistical Methods: General
  • Geneeskunde (GENK)
  • Geneeskunde(GENK)
  • Bescherming en bevordering van de menselijke gezondheid
  • Other medical specialities

Cite this